Properdin

CFP
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesCFP, BFD, PFC, PFD, PROPERDIN, complement factor properdin, properdin
External IDsOMIM: 300383 MGI: 97545 HomoloGene: 1969 GeneCards: CFP
Orthologs
SpeciesHumanMouse
Entrez

5199

18636

Ensembl

ENSG00000126759

ENSMUSG00000001128

UniProt

P27918

P11680

RefSeq (mRNA)

NM_002621
NM_001145252

NM_008823

RefSeq (protein)

NP_001138724
NP_002612

NP_032849

Location (UCSC)Chr X: 47.62 – 47.63 MbChr X: 20.93 – 20.93 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Properdin is protein that in humans is encoded by the CFP (complement factor properdin) gene.

Properdin is plasma glycoprotein that activates the complement system of the innate immune system. This protein binds to bacterial cell walls and dying humans cells to stabilize the C3 and C5-convertase enzyme complexes to form an attack complex that lead to the lysis of the cell.

Structure

Properdin is a gamma globulin protein composed of multiple identical protein subunits with a separate ligand-binding site. Native properdin occurs in head-to-tail dimers, trimers and tetramers in the fixed ratio 22:52:28.[5]

Function

It is known that it participates in some specific immune responses. It plays a part in tissue inflammation as well as the engulfing of pathogens by phagocytes. In addition it is known to help to neutralize some viruses.

The properdin promotes the association of C3b with Factor B and provides a focal point for the assembly of C3bBb on a surface. It binds to preformed alternative pathway C3-convertases.[6] Properdin also inhibits the Factor H – mediated cleavage of C3b by Factor I.

Alternative pathway. Properdin is the "P" in the blue circles. (Some labels are in Polish.)

The alternative pathway is not dependent on antibodies. This branch of the complement system is activated by IgA immune complexes and bacterial endotoxins, polysaccharides, and cell walls, and results in producing anaphylatoxins, opsonins, chemotactic factors, and the membrane attack complex, all of which help fight pathogens.

History

Properdin was discovered in 1954 by Dr. Louis Pillemer of the Institute of Pathology (now the Department of Pathology at Case Western Reserve University).

Deficiency

Properdin deficiency is a rare X-linked disease in which properdin is deficient. Affected individuals are susceptible to fulminant meningococcal disease.[7]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000126759 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000001128 - Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ Smith C, Pangburn M, Vogel CW, Müller-Eberhard H (1984). "Molecular Architecture of Human Properdin, a Positive Regulator of the Alternative Pathway of Complement". J Biol Chem. 259 (7): R4582–4588. doi:10.1016/S0021-9258(17)43086-9.
  6. ↑ Hourcade D (2006). "The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement". J Biol Chem. 281 (4): R2128–2132. doi:10.1074/jbc.m508928200. PMID 16301317.
  7. ↑ Dr. Lars Otto Uttenthal Properdin September 01 2005 Archived 2012-04-02 at the Wayback Machine
  • Properdin at the US National Library of Medicine Medical Subject Headings (MeSH)
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.